February 05, 2013
Merck & Co. Inc. suffered a blow during the last bellwether trial in multidistrict litigation alleging bone drug Fosamax causes jaw deterioration, as a New York federal jury ruled Tuesday that the pharmaceutical giant failed to properly warn of the treatment's risks.
November 21, 2012
The New York federal judge overseeing multidistrict litigation that includes more than 950 suits alleging Merck &. Co. Inc.'s osteoporosis drug Fosamax causes jaw deterioration granted a so-called Lone Pine order on Tuesday requiring some plaintiffs to support their claims with expert reports.
March 02, 2012
The Virginia Supreme Court ruled Friday that a proposed class action over Merck & Co. Inc.'s Fosamax did not postpone the statute of limitations for unnamed class members who launched individual suits claiming the osteoporosis drug causes jaw deterioration.
November 28, 2011
A New York federal judge last week chose a Fordham University School of Law professor as a special master tasked with brokering a settlement of roughly 900 suits consolidated in a multidistrict litigation alleging Merck & Co. Inc.'s Fosamax causes jaw deterioration.
October 03, 2011
A New York federal jury on Monday sided with Merck & Co. Inc. in a bellwether case in multidistrict litigation alleging Fosamax causes jaw deterioration — the fourth jury to do so in litigation over the osteoporosis drug.
August 30, 2011
A New York federal judge on Tuesday dismissed every claim but one in a bellwether case in multidistrict litigation alleging Merck & Co. Inc.'s osteoperosis drug Fosamax causes jaw deterioration, allowing only a design defect claim to stand for trial.
February 08, 2011
Merck & Co. will help select two additional bellwether cases for trial in a multidistrict litigation over its osteoporosis drug Fosamax following a federal judge's ruling that a couple of key issues still needed to be hashed out in court.
October 10, 2007
Merck and the patients who sued over its bone drug Fosamax are sparring over who should fund discovery requests in the multidistrict litigation.